Vista.ai Names Steve Cashman to Board of Directors

2023-09-14
高管变更并购
PALO ALTO, Calif., Sept. 14, 2023 /PRNewswire/ -- Vista.ai, a pioneer in AI-assisted MRI solutions, today announced it has named Steve Cashman to its Board of Directors. The announcement comes at a time where the company is seeing significant adoption of its products.
"We are thrilled to welcome Steve to our Board of Directors," said Juan Santos, Vista.ai's CEO. "Steve is a seasoned executive in the healthcare AI automation space. His deep understanding of the challenges and opportunities in this market will be invaluable in helping us grow our sales and innovate our products."
Steve Cashman is an entrepreneur with deep experience in healthcare and has a track record of delivering exceptional results. He is passionate about technology's ability to transform the patient's experience and access to healthcare. He brings simple values and a commonsense approach to building winning teams, creating a client-first culture, and driving innovation that transforms the market.
Most recently he led development and commercialization of the industry's first AI-powered ultrasound platform as President & CEO of Caption Health, acquired by GE Healthcare.
Prior to leading Caption Health, Steve was CCO at InTouch Health (acquired by Teladoc), where he oversaw domestic and global growth, as well as product, marketing, customer service, and clinical services. He is actively engaged in the business startup community, is an angel investor, and is on the Board of Stowe Mission.
"Vista.ai's recent successes in partnering with the world's most renowned cardiology centers is truly impressive," said Steve. "By automating and speeding up these complex cardiac MRI exams, while delivering consistent and accurate images, Vista.ai is bringing this lifesaving diagnostic technology to all. I am committed to working with Vista.ai to make their vision a reality and help ensure that everyone has access to this technology."
About Vista.ai
Vista.ai is harnessing the power of artificial intelligence (AI) to offer clinicians an easy, cost-effective and less stressful way to conduct MRI studies. The company's FDA 510(k) cleared One Click MRI™ software-only solution automates and dramatically simplifies a CMR exam, enabling a hospital to obtain greater scanner throughput or get a CMR program off the ground cost-effectively. One Click MRI is available for use on Siemens Healthineers and GE Healthcare MRI scanners. For more information, please visit www.vista.ai.
Contact
[email protected]
SOURCE Vista.ai
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。